Announces New Chief Scientific Officer
Aspira Women’s Health announced it has named Jody Berry, Ph.D as its new Chief Scientific Officer. Dr. Ryan Phan, who stepped down from the position, remains as an advisor through the end of the year to help with the transition and provide scientific and operational advice related to ongoing product development programs. Dr. Berry is a recognized international expert in immunoassay development, antibody technology, and infectious diseases. Dr. Berry joins AWH from OraSure Technologies, Inc. where he served as Chief Science Officer responsible for all innovation and product development, including the breakthrough discovery of the first integrated swab test for COVID-19. Prior to that, he led immunohistochemistry research and development for Grifols Diagnostics Solutions. He has also served in senior scientific and executive leadership roles for BD Biosciences and Cangene Corporation. Prior to that, he served as Head of Monoclonal Antibody and Bioforensics Response at the National Microbiology Lab at the Public Health Agency of Canada. Dr. Berry has served as visiting or adjunct professor at Lehigh University, the University of Western Michigan, and the University of Manitoba. He is the recipient of numerous awards, including the Knudsen Memorial Publication Award from the American Biological Safety Association, the Government of Canada Public Service Commendation Award for post 9/11, CHIR JIV/AIDS Postdoctoral Fellowships, and the Apotex Fermentation Inc. Research Award for Doctoral Research in Molecular Biology. He is the author or co-author of more than 100 peer-reviewed published journal articles, abstracts, scientific posters, and monographs. Dr. Berry earned a Bachelor of Science with honors from the Department of Microbiology and his Doctor of Philosophy from the University of Manitoba. He completed his post-doctoral fellowship at the Scripps Research Institute, Department of Molecular Biology where he was the first to create immune antibody libraries to HIV to cervical B cells collected from HIV-1 exposed, but uninfected subjects in Kenya.
Water Tower Research is built on the foundation of democratizing information flow. We bridge the growing information gap between companies and investors through our investor engagement strategies and open-access research platform.
Our research analysts are Wall Street veterans with the experience and knowledge to work with companies and investors in tandem. We provide access to the information and content that anchors the due diligence process for both professional money managers and individual investors. We leverage traditional research distribution channels and the best of modern digital strategies and tactics to amplify this information flow globally to engage all categories of investors and stakeholders.
Information flow is the foundation for creating investor awareness, knowledge, and engagement. Our mission is to help companies and investors have the tools they need and achieve their goals.
Unfortunately, this report is not available for the investor type or country you selected.
Browse all ResearchPool reportsReport is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.